Budget impact of introducing tildrakizumab for the treatment of moderate to severe plaque psoriasis in the United States
Carrico, J., Zhao, Y., Jia, X., Brodtkorb, T-H., A, M., & Lowry, S. (2018). Budget impact of introducing tildrakizumab for the treatment of moderate to severe plaque psoriasis in the United States. Journal of managed care & specialty pharmacy, 24(10-a Suppl), S78-S79. https://doi.org/10.18553/jmcp.2018.24.10-a.s1
Abstract
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.